{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:59:59Z","timestamp":1783979999673,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with primary aldosteronism have a higher risk of chronic kidney disease. Visceral fat tissue is hypothesized to stimulate the adrenal glands to overproduce aldosterone, and aldosterone promotes visceral fat tissue to produce inflammatory cytokines. However, it is unclear whether the volume of accumulated visceral fat tissue is associated with renal impairment among patients with hyperaldosteronism. We conducted a single-center cross-sectional study to assess the association between the estimated glomerular filtration rate and the ratio of the visceral-to-subcutaneous fat volume calculated by computed tomography. One hundred eighty patients with primary aldosteronism were enrolled. The mean\u2009\u00b1\u2009SD age was 52.7\u2009\u00b1\u200911.0 years, and 60.0% were women. The ratio of visceral-to-subcutaneous fat volume was highly correlated with the estimated glomerular filtration rate (<jats:italic>r<\/jats:italic>\u2009=\u20090.49, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). In multiple linear regression models, the ratio of visceral-to-subcutaneous fat tissue volume was significantly associated with the estimated glomerular filtration rate (estimates: \u22124.56\u2009mL\/min\/1.73\u2009m\u00b2 per 1-SD), and there was an interaction effect between the plasma aldosterone concentration and the ratio of visceral-to-subcutaneous fat volume (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). The group with a higher plasma aldosterone concentration exhibited a steeper decline in eGFR than the lower plasma aldosterone concentration group when the ratio increased. The ratio of visceral-to-subcutaneous fat tissue volume was an independent risk factor for renal dysfunction. This association increased in the presence of a high plasma aldosterone concentration. Clinicians should pay attention to the ratio of visceral-to-subcutaneous fat tissue volume and encourage primary aldosteronism patients to improve their lifestyle in addition to treating renin-aldosterone activity.<\/jats:p>","DOI":"10.1038\/s41440-021-00719-w","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T04:03:03Z","timestamp":1628222583000},"page":"1341-1351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism"],"prefix":"10.1038","volume":"44","author":[{"given":"Tatsuya","family":"Haze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ohki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Saka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Hirawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"key":"719_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","volume":"107","author":"JW Conn","year":"1964","unstructured":"Conn JW, Knopf RF, Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg. 1964;107:159\u201372.","journal-title":"Am J Surg"},{"key":"719_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009. Endocr J. 2011;58:711\u201321.","journal-title":"Endocr J"},{"key":"719_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrneph.2010.30","volume":"6","author":"M Briet","year":"2010","unstructured":"Briet M, Schiffrin EL. Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol. 2010;6:261\u201373.","journal-title":"Nat Rev Nephrol"},{"key":"719_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrneph.2013.110","volume":"9","author":"NJ Brown","year":"2013","unstructured":"Brown NJ. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol. 2013;9:459\u201369.","journal-title":"Nat Rev Nephrol"},{"key":"719_CR5","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Arg\u00fceso M, Pascual-Corrales E, Rojano NB, Cano AG, Mendiguch\u00eda LJ, Araujo-Castro M. Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study. Endocrine. 2021.","DOI":"10.21203\/rs.3.rs-238982\/v1"},{"key":"719_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","volume":"72","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Renal outcomes in medically and surgically treated primary aldosteronism. Hypertension. 2018;72:658\u201366.","journal-title":"Hypertension"},{"key":"719_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.mayocp.2017.12.012","volume":"93","author":"N Covassin","year":"2018","unstructured":"Covassin N, Sert-Kuniyoshi FH, Singh P, Romero-Corral A, Davison D, Lopez-Jimenez F, et al. Experimental weight gain increases ambulatory blood pressure in healthy subjects: implications of visceral fat accumulation. Mayo Clin Proc. 2018;93:618\u201326.","journal-title":"Mayo Clin Proc"},{"key":"719_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10157-020-01921-9","volume":"24","author":"Y Miyasato","year":"2020","unstructured":"Miyasato Y, Oba K, Yasuno S, Matsuyama Y, Masuda I. Associations between visceral obesity and renal impairment in health checkup participants: a retrospective cohort study. Clin Exp Nephrol. 2020;24:935\u201345.","journal-title":"Clin Exp Nephrol"},{"key":"719_CR9","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"J-P Despr\u00e9s","year":"2006","unstructured":"Despr\u00e9s J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881\u20137.","journal-title":"Nature"},{"key":"719_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jcjd.2018.08.199","volume":"43","author":"Y Wang","year":"2019","unstructured":"Wang Y, Chen F, Wang J, Wang T, Zhang J, Han Q, et al. The relationship between increased ratio of visceral-to-subcutaneous fat area and renal outcome in Chinese adults with type 2 diabetes and diabetic kidney disease. Can J Diabetes 2019;43:415\u201320.","journal-title":"Can J Diabetes"},{"key":"719_CR11","doi-asserted-by":"publisher","first-page":"14211","DOI":"10.1073\/pnas.2336140100","volume":"100","author":"M Ehrhart-Bornstein","year":"2003","unstructured":"Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, et al. Human adipocytes secrete mineralocorticoid-releasing factors. PNAS. 2003;100:14211\u20136.","journal-title":"PNAS"},{"key":"719_CR12","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","volume":"132","author":"A-C Huby","year":"2015","unstructured":"Huby A-C, Antonova G, Groenendyk J, Gomez-Sanchez CE, Bollag WB, Filosa JA, et al. Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis. Circulation 2015;132:2134\u201345.","journal-title":"Circulation"},{"key":"719_CR13","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","volume":"117","author":"C Guo","year":"2008","unstructured":"Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR. et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, PPAR\u03b3 and pro-inflammatory adipokines. Circulation. 2008;117:2253\u201361.","journal-title":"Circulation"},{"key":"719_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"719_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"Rossi GP, Auchus RJ, Brown M, Lenders JWM, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 2014;63:151\u201360.","journal-title":"Hypertension"},{"key":"719_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.14310\/horm.2002.1342","volume":"11","author":"V Salem","year":"2012","unstructured":"Salem V, Hopkins TG, El-Gayar H, Zac-Varghese S, Goldstone AP, Todd JF, et al. Adrenal venous sampling as a diagnostic procedure for primary hyperaldosteronism: experience from a tertiary referral centre. Hormones. 2012;11:151\u20139.","journal-title":"Hormones"},{"key":"719_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJE Kempers","year":"2009","unstructured":"Kempers MJE, Lenders JWM, van Outheusden L, van der Wilt GJ, Schultze Kool LJ, Hermus ARMM, et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009;151:329\u201337.","journal-title":"Ann Intern Med"},{"key":"719_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.ajkd.2010.02.344","volume":"56","author":"M Horio","year":"2010","unstructured":"Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis. 2010;56:32\u201338.","journal-title":"Am J Kidney Dis"},{"key":"719_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.2040-1124.2010.00074.x","volume":"1","author":"Y Seino","year":"2010","unstructured":"Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2010;1:212\u201328.","journal-title":"J Diabetes Investig"},{"key":"719_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.5551\/jat.15792","volume":"20","author":"T Teramoto","year":"2012","unstructured":"Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, et al. Diagnostic criteria for dyslipidemia executive summary of the Japan atherosclerosis society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan\u20142012 version. J Atheroscler Thromb. 2012;20:517\u201323.","journal-title":"J Atheroscler Thromb"},{"key":"719_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377\u201399.","journal-title":"Stat Med"},{"key":"719_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10157-018-1648-1","volume":"23","author":"H Okada","year":"2019","unstructured":"Okada H, Yasuda Y, Kashihara N, Asahi K, Ito T, Kaname S, et al. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018. Clin Exp Nephrol. 2019;23:1\u201315.","journal-title":"Clin Exp Nephrol"},{"key":"719_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","volume":"63","author":"LA Inker","year":"2014","unstructured":"Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713\u201335.","journal-title":"Am J Kidney Dis"},{"key":"719_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/EJE-19-0047","volume":"181","author":"A Kawashima","year":"2019","unstructured":"Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I. et al. Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism. Eur J Endocrinol. 2019;181:339\u201350.","journal-title":"Eur J Endocrinol"},{"key":"719_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/187152608784139631","volume":"8","author":"V Pallottini","year":"2008","unstructured":"Pallottini V, Bulzomi P, Galluzzo P, Martini C, Marino M. Estrogen regulation of adipose tissue functions: involvement of estrogen receptor isoforms. Infect Disord Drug Targets. 2008;8:52\u201360.","journal-title":"Infect Disord Drug Targets"},{"key":"719_CR26","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero P, Paglieri C, Morello F, Chiandussi L. Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002;40:897\u2013902.","journal-title":"Hypertension"},{"key":"719_CR27","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1210\/jcem.87.6.8567","volume":"87","author":"Y Miyazaki","year":"2002","unstructured":"Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K. et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab. 2002;87:2784\u201391.","journal-title":"J Clin Endocrinol Metab"},{"key":"719_CR28","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00394-015-0923-0","volume":"55","author":"A Ogna","year":"2016","unstructured":"Ogna A, Ogna VF, Bochud M, Guessous I, Paccaud F, Burnier M. et al. Association between obesity and glomerular hyperfiltration: the confounding effect of smoking and sodium and protein intakes. Eur J Nutr. 2016;55:1089\u201397.","journal-title":"Eur J Nutr"},{"key":"719_CR29","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1097\/HJH.0b013e328354f65b","volume":"30","author":"S Terata","year":"2012","unstructured":"Terata S, Kikuya M, Satoh M, Ohkubo T, Hashimoto T, Hara A, et al. Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study. J Hypertens. 2012;30:1632\u20138.","journal-title":"J Hypertens"},{"key":"719_CR30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/cvr\/cvx097","volume":"113","author":"G Jia","year":"2017","unstructured":"Jia G, Aroor AR, Sowers JR. The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall. Cardiovasc Res. 2017;113:1055\u201363.","journal-title":"Cardiovasc Res"},{"key":"719_CR31","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/ijms21030978","volume":"21","author":"L D\u2019Marco","year":"2020","unstructured":"D\u2019Marco L, Puchades MJ, Gorriz JL, Romero-Parra M, Lima-Mart\u00ednez M, Soto C. et al. Epicardial adipose tissue, adiponectin and leptin: a potential source of cardiovascular risk in chronic kidney disease. Int J Mol Sci. 2020;21:978","journal-title":"Int J Mol Sci"},{"key":"719_CR32","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.HYP.0000129281.03801.4b","volume":"43","author":"Y Iwashima","year":"2004","unstructured":"Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004;43:1318\u201323.","journal-title":"Hypertension"},{"key":"719_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1210\/jc.2003-031012","volume":"89","author":"K Tan","year":"2004","unstructured":"Tan K, Xu A, Chow WS, Lam MCW, Ai VHG, Tam SCF, et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab. 2004;89:765\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"719_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.108.124255","volume":"53","author":"AL Mark","year":"2009","unstructured":"Mark AL, Agassandian K, Morgan DA, Liu X, Cassell MD, Rahmouni K. Leptin signaling in the nucleus tractus solitarii increases sympathetic nerve activity to the kidney. Hypertension. 2009;53:375\u20138.","journal-title":"Hypertension"},{"key":"719_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/01.ATV.0000110908.43721.ad","volume":"24","author":"N Werner","year":"2004","unstructured":"Werner N, Nickenig G. From fat fighter to risk factor. Arterioscler Thromb Vasc Biol. 2004;24:7\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"719_CR36","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1046\/j.1523-1755.1999.00626.x","volume":"56","author":"G Wolf","year":"1999","unstructured":"Wolf G, Hamann A, Han DC, Heimchen U, Thaiss F, Ziyadeh FN. et al. Leptin stimulates proliferation and TGF-\u03b2 expression in renal glomerular endothelial cells: Potential role in glomerulosclerosis. Kidney Int. 1999;56:860\u201372.","journal-title":"Kidney Int"},{"key":"719_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","volume":"257","author":"Y Arita","year":"1999","unstructured":"Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J-I, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"719_CR38","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1161\/HYPERTENSIONAHA.109.141119","volume":"55","author":"LJ Prior","year":"2010","unstructured":"Prior LJ, Eikelis N, Armitage JA, Davern PJ, Burke SL, Montani J-P. et al. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension. 2010;55:862\u20138.","journal-title":"Hypertension"},{"key":"719_CR39","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/01.ATV.21.6.961","volume":"21","author":"I Lemieux","year":"2001","unstructured":"Lemieux I, Pascot A, Prud\u2019homme D, Alm\u00e9ras N, Bogaty P, Nadeau A. et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001;21:961\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"719_CR40","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Investig 2003;112:1796\u2013808.","journal-title":"J Clin Investig"},{"key":"719_CR41","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2337\/db06-1656","volume":"56","author":"L Fontana","year":"2007","unstructured":"Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010\u20133.","journal-title":"Diabetes"},{"key":"719_CR42","doi-asserted-by":"publisher","first-page":"e0241626","DOI":"10.1371\/journal.pone.0241626","volume":"15","author":"H Kataoka","year":"2020","unstructured":"Kataoka H, Mochizuki T, Iwadoh K, Ushio Y, Kawachi K, Watanabe S, et al. Visceral to subcutaneous fat ratio as an indicator of a \u226530% eGFR decline in chronic kidney disease. PLoS ONE. 2020;15:e0241626.","journal-title":"PLoS ONE"},{"key":"719_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/oby.2006.43","volume":"14","author":"JL Kuk","year":"2006","unstructured":"Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat is an independent predictor of all cause mortality in men. Obesity. 2006;14:336\u201341.","journal-title":"Obesity"},{"key":"719_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1210\/en.2010-0674","volume":"152","author":"M Caprio","year":"2011","unstructured":"Caprio M, Antelmi A, Chetrite G, Muscat A, Mammi C, Marzolla V, et al. Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome. Endocrinology. 2011;152:113\u201325.","journal-title":"Endocrinology"},{"key":"719_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1055\/s-2005-870240","volume":"37","author":"D Kraus","year":"2005","unstructured":"Kraus D, J\u00e4ger J, Meier B, Fasshauer M, Klein J. Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res. 2005;37:455\u20139.","journal-title":"Horm Metab Res"},{"key":"719_CR46","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/sj.ijo.0803761","volume":"32","author":"TB Chaston","year":"2008","unstructured":"Chaston TB, Dixon JB. Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes. 2008;32:619\u201328.","journal-title":"Int J Obes"},{"key":"719_CR47","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1210\/js.2018-00187","volume":"2","author":"Y Shibayama","year":"2018","unstructured":"Shibayama Y, Wada N, Baba S, Miyano Y, Obara S, Iwasaki R, et al. Relationship between visceral fat and plasma aldosterone concentration in patients with primary aldosteronism. J Endocr Soc. 2018;2:1236\u201345.","journal-title":"J Endocr Soc"},{"key":"719_CR48","doi-asserted-by":"publisher","first-page":"e001153","DOI":"10.1136\/bmjdrc-2019-001153","volume":"8","author":"LK Er","year":"2020","unstructured":"Er LK, Lin M-C, Tsai Y-C, Hsiao J-K, Yang C-Y, Chang C-C, et al. Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma. BMJ Open Diab Res Care. 2020;8:e001153.","journal-title":"BMJ Open Diab Res Care"},{"key":"719_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6823-12-1","volume":"12","author":"CM O\u2019Seaghdha","year":"2012","unstructured":"O\u2019Seaghdha CM, Hwang S-J, Vasan RS, Larson MG, Hoffmann U, Wang TJ, et al. Correlation of renin angiotensin and aldosterone system activity with subcutaneous and visceral adiposity: the framingham heart study. BMC Endocr Disord. 2012;12:1\u20137.","journal-title":"BMC Endocr Disord"},{"key":"719_CR50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/j.1550-8528.1999.tb00418.x","volume":"7","author":"TL Goodfriend","year":"1999","unstructured":"Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res. 1999;7:355\u201362.","journal-title":"Obes Res"},{"key":"719_CR51","doi-asserted-by":"publisher","first-page":"H1577","DOI":"10.1152\/ajpheart.01255.2008","volume":"296","author":"B Xue","year":"2009","unstructured":"Xue B, Daniel Badaue-Passos J, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Sex differences and central protective effect of 17\u03b2-estradiol in the development of aldosterone\/NaCl-induced hypertension. Am J Physiol Heart Circ Physiol. 2009;296:H1577\u2013H1585.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"719_CR52","doi-asserted-by":"publisher","first-page":"R1220","DOI":"10.1152\/ajpregu.00864.2007","volume":"294","author":"JC Sullivan","year":"2008","unstructured":"Sullivan JC. Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. Am J Physiol Regul Integr Comput Physiol. 2008;294:R1220\u2013R1226.","journal-title":"Am J Physiol Regul Integr Comput Physiol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00719-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00719-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00719-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T14:07:09Z","timestamp":1675606029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00719-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1038\/s41440-021-00719-w","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]},"assertion":[{"value":"4 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}